Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and Healthcare sectors 01262022170159
Executive Insights Life Sciences & Pharma The Inflation Reduction Act: Implications for Drug Delivery Innovation January 3, 2024
Executive Insights Mental and Behavioral Health Mind-Altering Metamorphosis: Transforming the Patient Journey in Mental Health October 13, 2023
Executive Insights Diagnostics, Tools and Personalized Medicine Creating a Vibrant Ecosystem for Precision Medicine: A Prescription for Success July 6, 2023
Executive Insights Life Sciences & Pharma Cash Preservation in the Biopharmaceutical Industry: Navigating Uncertainty June 22, 2023